Search | TVST | ARVO Journals

Showing 1 – 20 of 45

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Intergenerational utility in parents of children with amblyopia

Geertje van der Sterre; H.M. van der Meulen-Schot; E. Abma-Bustraan; E.S. van de Graaf; Huibert Jan Simonsz

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1250 – A0358. doi:

ARVO Annual Meeting Abstract June 2022

Indications for and effect of nasal and temporal partial tenotomy of the vertical rectus muscles in strabismus

Parinaz Rostamzad; Helma M. van der Meulen-Schot; Huibert Jan Simonsz; Sjoukje E Loudon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3669 – A0326. doi:

ARVO Annual Meeting Abstract June 2022

Do families prefer gaming to patching? A qualitative study on experiences and preferences with amblyopia treatment.

Emily Tan; Aveen Kadhum; Annemieke Treur; Janna Bruijning; Maurits V. Joosse; Huibert Jan Simonsz; Sjoukje E Loudon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1248 – A0356. doi:

ARVO Annual Meeting Abstract June 2022

Dose-response relationship and treatment efficiency for patching vs gaming therapy for amblyopia

Aveen Kadhum; Emily Tan; Maria Fronius; Maurits V. Joosse; Huibert Jan Simonsz; Sjoukje E Loudon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2286. doi:

ARVO Annual Meeting Abstract June 2022

Availability of data for cost-effectiveness comparison of vision screening programmes

Huibert Jan Simonsz; Jan Kik; Eveline Heijnsdijk; Allison Mackey; Gwen Carr; Anna Horwood; Maria Fronius; Jill Carlton; Inger Uhlén

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3838. doi:

ARVO Annual Meeting Abstract June 2022

Botulinum toxin as adjuvant to rectus muscle surgery in high myopia

Sjoukje E Loudon; Gerdien Holtslag; Huibert Jan Simonsz

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3666 – A0323. doi:

ARVO Annual Meeting Abstract June 2021

The effect of patching and gaming therapy on visual acuity in children with amblyopia and influence on quality of life

Aveen Kadhum; Emily Tan; Janna Bruijning; Maurits V Joosse; Huibert Jan Simonsz; Sjoukje E Loudon

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):159. doi:

ARVO Annual Meeting Abstract June 2021

EUSCREEN APP calculates the cost-effectiveness of vision screening programs, taking local circumstances into account

Huibert Jan Simonsz; Hans Hoeve; Eveline Heijnsdijk; Jan Kik; Anna Horwood; Inger Úhlen; Gwen Carr; Mandy Nordmann; Harry de Koning

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):148. doi:

ARVO Annual Meeting Abstract June 2021

Preparation of the Early Glasses Study: a randomized, controlled trial investigating the effect of early glasses for high refractive error on the development of amblyopia

Annelies Bruinenberg; Mandy Nordmann; Wijnanda L Asjes - Tydeman; Daisy Sanders; Rinske van Ommen; Janine Benjamins; Jeanne-Marie Hament; Chantal WF Wiersma-Hartman; Inge Tissen; Nienke Boonstra; Huibert Jan Simonsz

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):145. doi:

ARVO Annual Meeting Abstract June 2021

Intergenerational utility in parents of children with amblyopia

Geertje van der Sterre; H.M. van der Meulen-Schot; Ellen Abma-Bustraan; Huibert Jan Simonsz

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):152. doi:

ARVO Annual Meeting Abstract June 2020

The effect of patching and gaming therapy on visual acuity and stereoacuity in children with amblyopia

Sjoukje E Loudon; Aveen Kadhum; Emily Tan; Huibert Jan Simonsz

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):508. doi:

ARVO Annual Meeting Abstract June 2020

Comparing the effect of patching therapy with gaming for amblyopia in children: Hurdles and challenges

Emily Tan; Aveen Kadhum; Huibert Jan Simonsz; Sjoukje E Loudon

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):510. doi:

ARVO Annual Meeting Abstract June 2020

EUSCREEN model for calculation of cost-effectiveness of vision screening programs online

Huibert Jan Simonsz; Eveline Heijnsdijk; Jan Kik; Andrea Bussé; Mandy Nordmann; Mirjam Verkleij; Erhan Demirel; Harry de Koning

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):862. doi:

ARVO Annual Meeting Abstract July 2019

Landolt-C at 45 months by youth health-care physicians or nurses in Dutch population-wide vision screening

Marieke Alberdina Johanna Telleman; Frea Sloot; Janine S. Benjamins; Huibert Jan Simonsz

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4424. doi:

ARVO Annual Meeting Abstract July 2019

EUSCREEN study, stage 1: Data collection on vision and hearing screening programs in 40 European countries and Turkey, Israel, Russia, Malawi, Ruanda, Suth-Africa and India

Huibert Jan Simonsz; Jill Carlton; Helen Griffith; Inger Úhlen; Cristina Vladutiu; Monica Ghititu; Birkena Qirjazi; Enver Roshi; Anna Horwood; Maria Fronius; Hans Hoeve; Harry de Koning

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4427. doi:

ARVO Annual Meeting Abstract July 2019

Comparing the effect of patching therapy with gaming for amblyopia

Aveen Kadhum; Emily T.C. Tan; Gerdien Holtslag; Huibert Jan Simonsz; Sjoukje E Loudon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):216. doi:

ARVO Annual Meeting Abstract July 2018

Risk factors for visual acuity deterioration 15 years after occlusion therapy for amblyopia

Aveen Kadhum; Brigitte Simonsz-Tóth; Maurits Joosse; Huibert Jan Simonsz; Sjoukje E Loudon

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4123. doi:

ARVO Annual Meeting Abstract June 2017

Long-term visual outcome of occlusion therapy for amblyopia: a 10-year follow-up

Aveen Kadhum; Sanne Pijnenburg; Bronte Janszen; Brigitte Simonsz-Toth; Huibert Jan Simonsz; Sjoukje E Loudon

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2359. doi:

ARVO Annual Meeting Abstract June 2017

Preparation for the EUSCREEN Study: gathering data on vision and hearing screening programmes in 41 European countries

Aya Sami; Frea Sloot; Mirjana Bjeloš; Branka Stirn Kranjc; Mari Levin; Grazyna Greczka; Luc Stappaerts; Amra Nadarevic Vodencarevic; Davide Bottin; Sara McCullough; Andrea Langmann; Lotte Welinder; Veit Sturm; Huibert Jan Simonsz

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2360. doi:

ARVO Annual Meeting Abstract June 2017

Visual acuity measurement at 36 months in population-wide eye screening in the Netherlands: 17-22% failure rate

Marieke Alberdina Johanna Telleman; Frea Sloot; Merel de Winter; Dunja Lammers; Aya Sami; Janine Benjamins; Huibert Jan Simonsz

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2362. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Intergenerational utility in parents of children with amblyopia

Indications for and effect of nasal and temporal partial tenotomy of the vertical rectus muscles in strabismus

Do families prefer gaming to patching? A qualitative study on experiences and preferences with amblyopia treatment.

Dose-response relationship and treatment efficiency for patching vs gaming therapy for amblyopia

Availability of data for cost-effectiveness comparison of vision screening programmes

Botulinum toxin as adjuvant to rectus muscle surgery in high myopia

The effect of patching and gaming therapy on visual acuity in children with amblyopia and influence on quality of life

EUSCREEN APP calculates the cost-effectiveness of vision screening programs, taking local circumstances into account

Preparation of the Early Glasses Study: a randomized, controlled trial investigating the effect of early glasses for high refractive error on the development of amblyopia

Intergenerational utility in parents of children with amblyopia

The effect of patching and gaming therapy on visual acuity and stereoacuity in children with amblyopia

Comparing the effect of patching therapy with gaming for amblyopia in children: Hurdles and challenges

EUSCREEN model for calculation of cost-effectiveness of vision screening programs online

Landolt-C at 45 months by youth health-care physicians or nurses in Dutch population-wide vision screening

EUSCREEN study, stage 1: Data collection on vision and hearing screening programs in 40 European countries and Turkey, Israel, Russia, Malawi, Ruanda, Suth-Africa and India

Comparing the effect of patching therapy with gaming for amblyopia

Risk factors for visual acuity deterioration 15 years after occlusion therapy for amblyopia

Long-term visual outcome of occlusion therapy for amblyopia: a 10-year follow-up

Preparation for the EUSCREEN Study: gathering data on vision and hearing screening programmes in 41 European countries

Visual acuity measurement at 36 months in population-wide eye screening in the Netherlands: 17-22% failure rate

To View More...

You must be signed into an individual account to use this feature.